Medium materiality6/10
Celldex price target lowered to $60 from $62 at Canaccord
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Canaccord Genuity lowers Celldex target to $60 from $62; current price $35.66.
- Canaccord Genuity lowers Celldex target to $60 vs price $35.66.
Key facts
- 01
Target: $60
- 02
Posted price: $35.66
- 03
Analyst firm: Canaccord Genuity
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.